Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Antonia M. D. Churchhouse"'
Autor:
Gareth-Rhys Jones, Eleanor Watson, Ross J Porter, Shahida Din, Alexander R Robertson, Antonia M. D. Churchhouse, Katherine Quiohilag, Kathryn Kirkwood
Publikováno v:
Posters.
Publikováno v:
Journal of Crohn's & Colitis
Porter, R J, Arends, M J, Churchhouse, A M D & Din, S 2021, ' Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines ', Journal of Crohn's and Colitis . https://doi.org/10.1093/ecco-jcc/jjab102
Porter, R J, Arends, M J, Churchhouse, A M D & Din, S 2021, ' Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines ', Journal of Crohn's and Colitis . https://doi.org/10.1093/ecco-jcc/jjab102
The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of inflammatory bowel disease-associated colorectal cancer [IBD-CRC]. Inflammation can induce mutagenesis, and the relapsing–r
Autor:
Lowri A Griffiths, Jennifer Doig, Antonia M D Churchhouse, Faith C J Davies, Charlotte E Squires, Helen J Newbery, Catherine M Abbott
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41917 (2012)
Translation elongation factor isoform eEF1A2 is expressed in muscle and neurons. Deletion of eEF1A2 in mice gives rise to the neurodegenerative phenotype "wasted" (wst). Mice homozygous for the wasted mutation die of muscle wasting and neurodegenerat
Externí odkaz:
https://doaj.org/article/ece3cf6673794b6fbab4c8e83e32bd3d
Autor:
Cher Shiong Chuah, Gareth-Rhys Jones, Jennifer Veryan, Shahida Din, Nikolas Plevris, Mathew Lyons, P. Shasi, Angus Watson, John Todd, E. Saffouri, A Sengupta, Paul Brennan, Graham Naismith, M Groome, L Potts, Antonia M. D. Churchhouse, R. M. Allen, Philip Jenkinson, E. Donoghue, Craig Mowat, Daniel R. Gaya, W. L. Lam, S. Chaudhary, H. Jafferbhoy, Morag Jane MacMaster, David Watts, John Paul Seenan, I. D. R. Arnott, Diarmid Ian Sutherland, Charlie W. Lees, Jonathan Macdonald
Publikováno v:
Journal of Crohn'scolitis. 13(9)
Background & Aims Vedolizumab is an anti-a4b7 monoclonal antibody that is licensed for the treatment of moderate to severe Crohn’s disease and ulcerative colitis. The aims of this study were to establish the real-world effectiveness and safety of v
Autor:
Daniel R. Gaya, P Shasi, D Watts, Charlie W. Lees, P Baker, H Jafferbhoy, C Mowat, Emma Donoghue, John Paul Seenan, Andrea K Watson, Graham Naismith, E Saffouri, Morag MacMaster, John Todd, Nikolas Plevris, Max Groome, Phil Jenkinson, L Potts, Cher Chuah, Alan G. Shand, Colin L. Noble, Antonia M. D. Churchhouse, Jonathan Macdonald, Eleanor F Watson, J Veryan, A Sengupta, Paul Brennan, Shahida Din, R Allen, I. D. R. Arnott, G R Jones
Publikováno v:
IBD.
Introduction The GEMINI trials and an increasing body of real-world data have demonstrated the effectiveness and safety of vedolizumab (VDZ) in IBD. However, there is limited available data about its effect on hospitalisations and steroid use. Our ai
Autor:
Anoop S V, Shah, David A, McAllister, Rosamund, Mills, Kuan Ken, Lee, Antonia M D, Churchhouse, Kathryn M, Fleming, Elizabeth, Layden, Atul, Anand, Omar, Fersia, Nikhil V, Joshi, Simon, Walker, Allan S, Jaffe, Keith A A, Fox, David E, Newby, Nicholas L, Mills
Publikováno v:
The American Journal of Medicine
Background Lowering the diagnostic threshold for troponin is controversial because it may disproportionately increase the diagnosis of myocardial infarction in patients without acute coronary syndrome. We assessed the impact of lowering the diagnosti
Autor:
Simon Walker, Antonia M. D. Churchhouse, Mary Stoddart, Kuan Ken Lee, David E. Newby, Margaret MacLeod, Martin A. Denvir, David A. McAllister, Keith A.A. Fox, Nicholas L. Mills
Publikováno v:
Mills, N L, Lee, K K, McAllister, D A, Churchhouse, A M D, Macleod, M, Stoddart, M, Walker, S, Denvir, M A, Fox, K A A & Newby, D E 2012, ' Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction : cohort study ', British Medical Journal (BMJ), vol. 344, no. 7852, e1533 . https://doi.org/10.1136/bmj.e1533
ObjectiveTo assess the relation between troponin concentration, assay precision, and clinical outcomes in patients with suspected acute coronary syndrome.DesignCohort study.SettingTertiary centre in Scotland.Participants2092 consecutive patients admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78f1b422dbbaa134acacf385a18e6b88
https://www.pure.ed.ac.uk/ws/files/8109056/Implications_of_lowering_threshold_of_plasma_troponin_concentration_in_diagnosis_of_myocardial_infarction.pdf
https://www.pure.ed.ac.uk/ws/files/8109056/Implications_of_lowering_threshold_of_plasma_troponin_concentration_in_diagnosis_of_myocardial_infarction.pdf
Autor:
Catriona Graham, Antonia M. D. Churchhouse, Martin A. Denvir, David E. Newby, Atul Anand, Keith A.A. Fox, Simon Walker, Margaret MacLeod, Kuan Ken Lee, Anoop S V Shah, David Gamble, Elspeth E. Paterson, Nicholas L. Mills
Publikováno v:
JAMA. 305(12)
Although troponin assays have become increasingly more sensitive, it is unclear whether further reductions in the threshold of detection for plasma troponin concentrations will improve clinical outcomes in patients with suspected acute coronary syndr
Publikováno v:
Gut. 63:A1.2-A2
Introduction Patients with severe Ulcerative Colitis (UC) are commonly identified using the Truelove and Witts 1 criteria on presentation. The Travis 2 and Ho 3 scores are subsequently used to identify patients with severe UC who are at high risk of
Publikováno v:
Journal of Crohn's and Colitis. 8:S132
Background: Patients with severe Ulcerative Colitis (UC) are commonly identified using the Truelove and Witts [1] criteria on presentation. The Travis [2] and Ho [3] scores are subsequently used to identify patients with severe UC who are at high ris